Similar articles

• Expression of AFPmRNA in blood of patients with recurrent hepatocellular carcinoma.

  Liu Y, Zhang BH, Qian GX, Chen H, Wu MC. Liu Y, et al. Hepatobiliary Pancreat Dis Int. 2003 May;2(2):274-7. Hepatobiliary Pancreat Dis Int. 2003. PMID: 14599983
• Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?

  Jeng KS, Sheen IS, Tsai YC. Jeng KS, et al. Am J Gastroenterol. 2004 Aug;99(8):1503-9. doi: 10.1111/j.1572-0241.2004.30227.x. Am J Gastroenterol. 2004. PMID: 15307868
• Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.

  Jeng KS, Sheen IS, Tsai YC. Jeng KS, et al. Arch Surg. 2004 Oct;139(10):1055-60. doi: 10.1001/archsurg.139.10.1055. Arch Surg. 2004. PMID: 15492142
• [Liver transplantation for hepatocellular carcinoma].

  Tanaka A, Tanaka K, Kaihara S, Ueda M, Uemoto S, Kiuchi T, Egawa H. Tanaka A, et al. Nihon Rinsho. 2001 Oct;59 Suppl 6:705-16. Nihon Rinsho. 2001. PMID: 11762042 Review. Japanese. No abstract available.
• [AFP mRNA in the circulation].

  Matsumura M. Matsumura M. Nihon Rinsho. 2001 Oct;59 Suppl 6:377-82. Nihon Rinsho. 2001. PMID: 11761976 Review. Japanese. No abstract available.